FiNews

NextCell Pharma Q1 Operating Income SEK 2.8M

Author: Murat Tekinay

NextCell Pharma Q1 Financial Results

NextCell Pharma AB (OMXSTO:NXTCL) reported its first quarter financial results for 2026. The company's operating income reached SEK 2.8 million.

Net Sales and Cellaviva Contribution

Net sales for the quarter amounted to SEK 2.7 million, with SEK 2.6 million contributed by the Cellaviva segment.

Financial Performance

Profit/loss after financial items stood at SEK -10.4 million. For further details, refer to the official reports.

The news, analyses, and comments on this platform do not constitute investment advice. When making investment decisions, you should conduct your own research and consult with a qualified financial advisor if necessary. FiNews cannot be held responsible for any losses that may arise from the use of this information.